Abstract
Background:
Various studies suggest the hippocampus and serotonergic systems are important in the pathology of bipolar disorder (BD). We therefore measured hippocampal serotonergic markers in post-mortem tissue from BD and control subjects.
Methods:
The density and affinity of [3H]citalopram binding to the serotonin transporter (SERT), as well as the density of the 5HT(2A), 5HT(1A), 5HT(1D) and 5HT(1F) receptors were measured.
Results:
The density of SERT and 5HT receptors was no different in BD. There was a significant decrease in the affinity of [3H]citalopram binding to SERT in the stratum lacunosum-moleculare (S(lac)) in BD (K(d) mean+/-S.E.M.=4.3+/-0.8 vs. 1.9+/-0.3 nM).
Limitations:
This study was completed using relatively small cohorts.
Conclusions:
There are no generalised changes in hippocampal serotonergic markers in the hippocampus from subjects with BD. There is a decreased affinity of radioligand binding to S(lac) SERT in subjects with BD.
Publication types
-
Comparative Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Affinity Labels / pharmacokinetics
-
Binding Sites
-
Biomarkers
-
Bipolar Disorder / metabolism*
-
Bipolar Disorder / pathology*
-
Carrier Proteins / metabolism
-
Cell Count
-
Citalopram / pharmacokinetics*
-
Culture Techniques
-
Hippocampus / metabolism*
-
Hippocampus / pathology*
-
Humans
-
Ketanserin / pharmacokinetics
-
Membrane Glycoproteins / metabolism
-
Membrane Transport Proteins*
-
Nerve Tissue Proteins*
-
Receptors, Serotonin / metabolism*
-
Selective Serotonin Reuptake Inhibitors / pharmacokinetics*
-
Serotonin Antagonists / pharmacokinetics
-
Serotonin Plasma Membrane Transport Proteins
-
Serotonin Receptor Agonists / pharmacokinetics
-
Sumatriptan / pharmacokinetics
Substances
-
Affinity Labels
-
Biomarkers
-
Carrier Proteins
-
Membrane Glycoproteins
-
Membrane Transport Proteins
-
Nerve Tissue Proteins
-
Receptors, Serotonin
-
SLC6A4 protein, human
-
Serotonin Antagonists
-
Serotonin Plasma Membrane Transport Proteins
-
Serotonin Receptor Agonists
-
Serotonin Uptake Inhibitors
-
Citalopram
-
Sumatriptan
-
Ketanserin